The National Conference on Drug Registration Management and Post-Marketing Supervision in 2026 was held.

The national drug registration management and post-marketing supervision work conference for the year 2026 was held in Nanjing, Jiangsu Province on February 4th and 5th. The conference pointed out that 2026 is the beginning year of the "14th Five-Year Plan", and it is necessary to adhere to stability to promote progress, improve quality and efficiency, and ensure a good start for all work in the "14th Five-Year Plan". Firstly, it is necessary to strengthen and enhance the "firewall" of safety risks, improve risk prevention and control mechanisms, strengthen the supervision of the entire chain of clinical trials of drugs, high-risk variety supervision, and strengthen post-marketing supervision of drug contract manufacturing and other areas. Secondly, it is important to use the "catalyst" of reform to promote innovation, coordinate encouraging innovation and risk prevention, closely monitor the development of cutting-edge technologies, support the research and development and marketing of urgently needed clinical drugs, promote the implementation of drug trial data protection system, and improve the capability of drug evaluation, approval, supervision inspection, testing, and adverse reaction monitoring. Thirdly, it is essential to consolidate and improve the "base" of high-quality generic drug development, actively support the innovation and development of generic drugs, continuously improve the quality and efficiency of consistency evaluation work, strictly manage changes in generic drugs after they are marketed, and continuously strengthen the quality supervision of drugs selected in centralized procurement. Fourthly, it is necessary to intensify the "source cleaning" action to strengthen and improve drug network sales supervision, focus on increasing supervision of operational entities, establish and utilize a good drug information traceability system, effectively improve the efficiency and level of risk disposal and prevention in the drug operation process.